|
|
|
|
|
|
by klmr
841 days ago
|
|
|
> But in all honesty for the pharmaceutical industry it’s mostly momentum that keeps R on top I can’t agree with this: especially in PK/PD, R is only just now taking over from the previous (closed-source) systems. Momentum would keep R out, not in. |
|
|